Kyushu University Academic Staff Educational and Research Activities Database
List of Presentations
Hirata Miyuki Last modified date:2019.06.28

Assistant Professor / Social Medicine / Center for Cohort Studies / Faculty of Medical Sciences


Presentations
1. Akiyo Tanaka, Miyuki Hirata, Nagisa Matsumura, Masaharu Shiratani, Kazunori Koga, Yutaka Kiyohara, Health effects of indium nanoparticles. The 10th Asian-European International Conference on Plasma Surface Engineering, The 10th Asian-European International Conference on Plasma Surface Engineering, 2015.09.
2. Akiyo Tanaka, Miyuki Hirata, Nagisa Matsumura, Yutaka Kiyohara, Serum surfactant protein D is a marker of lung injury caused by indium chloride, 31th International Congress on Occupational Health, 2015.06.
3. Makiko Nakano, Akiyo Tanaka, Hirata Miyuki, Satoko Iwasawa, Kazuyuki Omae, Effects of Indium Metal Exposure on the Lungs of Japanese Workers. Cross–sectional Study., European Respiratory Society International Congress., 2014.09.
4. Akiyo Tanaka, Miyuki Hirata, Kazunori Koga, Masaharu Shiratani, Nagisa Matsumura, Yutaka Kiyohara, Subchronic Pulmonary Toxicity of Copper Indium Gallium Diselenide Following Repeated Intratracheal Instillations into the Lungs of Rats, The 21st Asian Conference on Occupational Health, 2014.09.
5. Satoko Iwasawa, Makiko Nakano, Hiroyuki Miyauchi, Akiyo Tanaka, Miyuki Hirata, Kazuyuki Omae, Shigeru Tanaka, Personal indium exposure concentration in respirable dusts and serum indium level, The 21st Asian Conference on Occupational Health, The 21st Asian Conference on Occupational Health, 2014.09.
6. Akiyo Tanaka, Hirata Miyuki, Kazunori Koga, Naho Itagaki, Masaharu Shiratani, Hayashi Nobuya, Giichiro Uchida, Subacute toxicity of gallium arsenide, indium arsenide and arsenic trioxide following intermittent intratracheal instillations to the lung of rats, 8th International Conference on Reactive Plasmas/31st Symposium on Plasma Processing, 2014.02, 金属化合物半導体の粉体をラットの気管内に投与し、亜慢性肺毒性を観察した.
7. Akiyo Tanaka, Hirata Miyuki, Kazunori Koga, Hayashi Nobuya, Masaharu Shiratani, Yutaka Kiyohara, Pulmonary Toxicity of copper indium gallium diselenide particles in rats, 6th International Symposium on Nanotechnology, Occupational and Environmental Health, 6th International Symposium on Nanotechnology, Occupational and Environmental Health, 2013.10, 金属化合物半導体のCIGS(銅-インジウム-ガリウム-セレン)粉体をラットの気管内に投与し、肺毒性を長期に観察した.
8. Kazunori Koga, Akiyo Tanaka, Hirata Miyuki, Hayashi Nobuya, Naho Itagaki, Giichiro Uchida, Comparative acute pulmonary toxicity of different types of indium-tin oxide following intermittent intratracheal instillation to the lung of rats, 2013 JSAP-MRS, 2013.09, 粒子径の異なるインジウムスズ酸化物(ITO)をラット気管内に投与し、肺毒性の違いについて調べた。.
9. Subchronic toxicity of cadmium telluride intratracheally instilled into rats.
10. Makiko Nakano, Akiyo Tanaka, Miyuki Hirata, Noriyuki Yoshioka, Kazuyuki Omae, Japanese indium cohort study: Five-year follow-up., The 23rd International Conference on Epidemiology in occupational Health, 2013.06, 日本国内にあるインジウム工場の作業者のインジウム健診の5年追跡結果を発表した。肺病変では、気腫性変化が増悪していた。.
11. Monitoring of total dust and indium dust in ITO workpalce.
12. Availability of electrically-powered mask agaist ITO dust.
13. Chronic toxicity of indium hydroxide intratracheally instilled into rats.
14. Synsethesis of indium nanomaterial by RF spattaring and metabolism of indium.
15. Health effects of indium.
16. Health effects of thin film solar cell element - Toxicity of indium compounds instilled intratracheally on animals -.
17. Indium cohort study with a chest computed tomography.
18. Hair indium of indium exposed workers.
19. Health effect of nanomaterial.
20. Health effect of old metal and new metal.
21. Urinary indium of indium exposed workers.
22. Pulmonary toxicity of cadmium telluride intratracheally instilled into rats.
23. Absorption,distribution, metabolism and excretion of indium compound.
24. Metabolism and pulmonary toxicity of solar cell consisted of copper-indium-gallium-diselenide following intratracheal instillations into the lungs of rats.
25. Absorption, distribution,metabolism and excretion of soluble indium compound.
26. Effect of intratracheal instillaiton of indium oxide to acatalasemic mice.
27. Effects of well dispersed multi-walled carbonnanotubes on the brain of rats.
28. Distribution of antimony following administration of antimony trioxide and antimony potassium tartrate via drinking water during 90days in rats.
29. Autoantibody against granulocyte macrophage colony-stimulating factor (GM-SCF) in heavily-exposed Japanese workers.
30. Effect of intratracheal instillation of Indium oxide to acatalasemic mice.
31. Biological effects of indium nanoparticle .
32. Biological monitaring of indium compounds: Outcomes of animal and epidemiological studies.
33. The metabolism and biological effect of indium trichloride after a single intratracheal instillation in rats.
34. Tissue distribution and excretion of indium trichloride after a single intratracheal instillation in rats.
35. The exposure effects of indium compounds on the lungs. The difference of the effects between target workers and refinary/recycle workers.
36. Absorption, metabolism, and excreation of indium compounds.
37. Effect of intratracheal instillation of indium oxide to acatalasemic mice.
38. Changes in serum indium concentration from the final intratracheal instillation.
39. Metal concentrations of the lung and serum following intratracheal instillation of CIGS in rats.
40. Four-year changes of effects of indium exposure on lungs - a Japanese indium cohort study -.
41. Pulmonary damage of organic or inorganic nano materials after intratracheal instillation to the lung of rats.
42. Risk assessment of inorganic nano materials in rats.
43. Change of biomarkers in blood among indium refinary workers after improvement of working environment.
44. Risk assessment of health effects of CIGS semiconductor solar cell. 1. Pulmonary effects..
45. Risk assessment of health effects of CIGS semiconductor solar cell. 2. Metal concentration in blood..
46. Adverse helth effects of CIGS particles after intratracheal instillations to the lung of rats. 1. The effects to the lung..
47. Adverse health effects of CIGS particlesafter intratracheal instillations to the lung of rats. 2. Metal concentration in blood.
48. Indium lung: Effects of improvement of working conditions on pulmonary interstitium.
49. Effects of improvement of working conditions on plmonary interstitium in indium-exposed workers.
50. Respiratory effects of indium: 1. Lung toxicity of indium-tin oxide, indium oxide and indium hydrate following repeated intratracheal instillations to the lung of rats.
51. Effects of antimony compounds in mice following oral administration via drinking water.
52. Efficacy and pharmacokinetics of arsenic trioxide for treatment of acute promyelocytic leukemia(APL) - Efficacy of As2O3 treatment -.
53. Efficacy and pharmacokinetics of arsenic trioxide for treatment of acute promyelocytic leukemia(APL) - Chemical speciation of arsenic metabolites in serum and urine -.
54. Efficacy and pharmacokinetics of arsenic trioxide for treatment of acute promyelocytic leukemia(APL).  2. Pharmacokinetics of As2O3.
55. Efficacy and pharmacokinetics of arsenic trioxide for treatment of acute promyelocytic leukemia(APL). 1. Efficacy of As2O3 treatmnet.
56. The effect of indium-tin oxide and indium oxide to the lung of hamsters following repeated intratracheal instillations.
57. Effects ofcarbon nanotube to the lung of rats by an intratracheal instillation.
58. Efficacy and pharmacokinetics of arsenic trioxide in a case of relapsed acute promyelocytic leukemia(APL).
59. Effects of antimony trioxide and antimony potassium tartrate in rats following 90-day administration via drinking water.
60. Comparative toxicity study of indium-tin oxide and indium phoshide following intratracheal instillations to the lung of hamsters.
2. Testicular toxicity.
61. Toxicity of indium-tin oxide and indium oxide.
62. Change in the testicular damage caused by indium-tin oxide and indium trioxide in hamsters after the repetitive intratracheal instillations.
63. Efficacy and pharmacokinetics of arsenic trioxide for treatment of acute promyelocytic leukemia(APL). Chemical speciation of arsenic metabolites in serum and urine.
64. Chronic toxicity of antimony compounds.
65. Pharmacokinetics of arsenic trioxide for treatment of acute promyelocytic leukemia(APL). Chemical speciation of arsenic metabolites in serum and urine.
66. Pulmonary toxicity of InAs, GaAs,AlGaAs following intratracheal instillation to the lung of Syrian golden hamsters.
67. Repeated intratracheal administrations of rare earth elements on rat.
- Distribution of administered elements -.
68. Comparative toxicity study of indium-tin oxide and indium phoshide following intratracheal instillations to the lung of hamsters.
1. Lung toxicity.
69. Distribution of tributyltin metabolites in the liver and brain of rats.
Evaluation in two-generation toxicity study of tributyltin chloride.
70. Tissue distribution of antimony in rats and mice following multiple oral administrations of antimony trioxide or antimony potassium tartrate.